Overview / Abstract: |
Target Audience Statement of Need/Program Overview Heavily treatment-experienced (HTE) patients with MDR have had few options specifically designed to supplement an optimized background regimen, but these options have expanded over the last several years, and there is hope that this small subset of patients will have even more options in the future. In this eHealth activity, Drs David Wohl and Jürgen Rockstroh discuss evaluation of VF, selection of subsequent regimens for patients experiencing VF, and recently approved and emerging options for HTE patients, including how to create and simplify salvage regimens for these patients. Educational Objectives Evaluate patient and genotypic causes of virologic failure Physician Accreditation Statement Physician Credit Designation Nurse Practitioner Continuing Education Instructions to Receive Credit Global Contact Information Integritas Contact Information Fee Information & Refund/Cancellation Policy Disclosures of Conflicts of Interest The faculty have the following relevant financial relationships with ineligible companies: Jürgen Rockstroh, MD: Consulting Fee: Abivax, Boehringer Ingelheim, Galapagos, Gilead Sciences, Inc., Janssen, Merck, Theratechnologies, ViiV; Contracted Research: Gilead Sciences, Inc., Merck, ViiV; Honoraria: Gilead Sciences, Inc., Merck, Theratechnologies, ViiV David A. Wohl, MD: Consulting Fee: Gilead Sciences, Inc., Janssen, Merck, ViiV; Contracted Research: Gilead Sciences, Inc., Merck, ViiV; Honoraria: Gilead Sciences, Inc., Janssen, Merck, ViiV The following planners and managers have no relevant financial relationships with ineligible companies: Kristin Delisi, NP, Lindsay Borvansky, Andrea Funk, Liddy Knight, Ashley Cann, Gena Dolson, MS, Jim Kappler, PhD Disclosure of Unlabeled Use Disclaimer |
Expiration |
Jun 17, 2023 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Monograph, Online |
Credits / Hours |
1.0 |
Accreditation |
This activity is jointly provided by Global Education Group and Integritas Communications. |
Is This Activity Certified for "Live" Credit? |
YES |
Presenters / Authors / Faculty |
Jürgen Rockstroh, MD David A. Wohl, MD |
Activity Specialities / Related Topics |
Infectious Disease |
Sponsors / Supporters / Grant Providers |
This activity is supported by an educational grant from Gilead Sciences, Inc. |
Keywords / Search Terms |
Integritas Communications HIV, virologic failure, ART, Rapid ART, anitretroviral, HTE, heavily treatment experienced, MDR, multi drug resistance Free CE CME Live CE CME |